Table 3 The association between the insulinemic dietary and lifestyle indices with the incidence of insulin resistance and metabolic syndrome: the Tehran Lipid and Glucose Study.

From: The association of dietary and lifestyle indices for insulin resistance with the risk of cardiometabolic diseases among Iranian adults

 

Insulin resistance

 

Metabolic syndrome

 

Tertiles of indices

P trend

Tertiles of indices

P trend

T1

T2

T3

T1

T2

T3

DIR

 Median score

− 0.04

0.05

0.18

 

− 0.04

0.05

0.18

 

 Case/Total

38/353

46/351

54/353

 

93/549

89/549

112/549

 

 Model 1*

1.00 (Ref)

1.40 (0.86–2.28)

1.74 (1.08–2.80)

0.023

1.00 (Ref)

1.05 (0.75–1.47)

1.41 (1.02–1.95)

0.030

 Model 2

1.00 (Ref)

1.38 (0.85–2.26)

1.71 (1.06–2.76)

0.028

1.00 (Ref)

1.05 (0.75–1.47)

1.41 (1.01–1.95)

0.032

 Model 3

1.00 (Ref)

1.34 (0.81–2.21)

1.65 (1.01–2.69)

0.047

1.00 (Ref)

1.03 (0.72–1.47)

1.32 (0.94–1.87)

0.091

LIR

 Median score

7.60

10.81

13.37

 

3.45

7.67

11.35

 

 Case/Total

26/349

38/350

73/349

 

57/543

86/545

150/543

 

 Model 1*

1.00 (Ref)

1.48 (0.86–2.54)

3.23 (1.97–5.30)

 < 0.001

1.00 (Ref)

1.36 (0.94–1.98)

2.76 (1.93–3.94)

 < 0.001

 Model 2

1.00 (Ref)

1.51 (0.88–2.59)

3.20 (1.95–5.25)

 < 0.001

1.00 (Ref)

1.39 (0.95–2.02)

2.81 (1.96–4.02)

 < 0.001

 Model 3

1.00 (Ref)

1.38 (0.79–2.40)

2.85 (1.72–4.73)

 < 0.001

1.00 (Ref)

1.15 (0.77–1.71)

2.87 (1.96–4.18)

 < 0.001

  1. *Model 1: adjusted for age and sex.
  2. Model 2: adjusted for model 1 and energy intake, smoking, education level, occupation status, and physical activity (only for DIR).
  3. Model 3: adjusted for model 2 and baseline VAI (for DIR) and TG to HDL-c ratio and waist residual BMI (for LIR).